Medicalsystem Biotechnology (300439) Stock Overview
Engages in the research, development, production, and sales of in vitro diagnostic products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
300439 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Medicalsystem Biotechnology Co., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥10.36 |
| 52 Week High | CN¥12.67 |
| 52 Week Low | CN¥9.40 |
| Beta | 0.16 |
| 1 Month Change | -1.89% |
| 3 Month Change | -3.18% |
| 1 Year Change | -11.00% |
| 3 Year Change | -26.00% |
| 5 Year Change | -48.28% |
| Change since IPO | -21.54% |
Recent News & Updates
Recent updates
Medicalsystem Biotechnology's (SZSE:300439) Solid Earnings May Rest On Weak Foundations
Nov 01
There's No Escaping Medicalsystem Biotechnology Co., Ltd's (SZSE:300439) Muted Earnings Despite A 39% Share Price Rise
Oct 08We Think That There Are Some Issues For Medicalsystem Biotechnology (SZSE:300439) Beyond Its Promising Earnings
Apr 30Shareholder Returns
| 300439 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -1.3% | -1.9% | 0.3% |
| 1Y | -11.0% | 1.9% | 16.6% |
Return vs Industry: 300439 underperformed the CN Biotechs industry which returned 1.9% over the past year.
Return vs Market: 300439 underperformed the CN Market which returned 16.6% over the past year.
Price Volatility
| 300439 volatility | |
|---|---|
| 300439 Average Weekly Movement | 2.7% |
| Biotechs Industry Average Movement | 4.2% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 9.1% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 300439 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300439's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 2,104 | Ji Hua Zou | www.nbmksw.com |
Medicalsystem Biotechnology Co., Ltd. engages in the research, development, production, and sales of in vitro diagnostic products in China. It is also involved in the provision of Three-party medical diagnosis services. The company offers automated chemistry analyzers; and automated chemiluminescence immunoassay analyzer; hematology analyzers and reagents; total laboratory automation system; mass spectrometry; and, blood lipid subfraction analyzer, and POCT
Medicalsystem Biotechnology Co., Ltd Fundamentals Summary
| 300439 fundamental statistics | |
|---|---|
| Market cap | CN¥3.97b |
| Earnings (TTM) | CN¥94.17m |
| Revenue (TTM) | CN¥1.47b |
Is 300439 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300439 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.47b |
| Cost of Revenue | CN¥892.90m |
| Gross Profit | CN¥578.48m |
| Other Expenses | CN¥484.31m |
| Earnings | CN¥94.17m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.25 |
| Gross Margin | 39.32% |
| Net Profit Margin | 6.40% |
| Debt/Equity Ratio | 0% |
How did 300439 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/05 14:14 |
| End of Day Share Price | 2025/12/05 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medicalsystem Biotechnology Co., Ltd is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiaxi Xu | Industrial Securities Co. Ltd. |
| Yuan Yuan Sun | Industrial Securities Co. Ltd. |
| Wei Zheng | Tianfeng Securities Brokerage Co., Ltd |